Cheaper growth factor therapy for bones on the horizon
This article was originally published in Clinica
Executive Summary
The US firm Interpore International, together with its partner Quantic Biomedical, has developed a way of extracting essential growth factors from a patient's own blood during the bone grafting process. This approach could slash the cost of growth factor treatment by 90% and reduce the overall cost of bone graft surgery.